defences against SSI 5 and because killing efficacy depends on the partial pressure of oxygen over the entire physiological range of tissue values. 6 7 For example, patients with low tissue oxygen partial pressure 3 or saturation 8 are more susceptible to wound infection and bowel anastomotic leaks after colorectal surgery. 9 Consistent with these observational data, supplemental inspired oxygen (which roughly doubles peripheral tissue oxygen partial pressure) reduces the risk of SSI in some, 10 11 but not all, 12 randomized trials.
Tissue oxygenation correlates with outcomes in nonsurgical settings such as heart failure. 13 Low or inadequate tissue oxygenation is also associated with specific perioperative complications including acute postoperative kidney injury, 14 septic shock, and acute systemic inflammatory conditions. 15 Because adequate tissue oxygenation is fundamental to cellular function, tissue hypoxia may be a root cause of many serious perioperative complications. The relationship of tissue oxygen saturation (StO 2 ) to immediate postoperative serious morbidity and mortality has not been fully characterized. We therefore tested the primary hypothesis that intraoperative and immediate postoperative tissue oxygen saturation in patients undergoing major noncardiac surgery, as measured at the thenar imminence with near-infrared spectroscopy (NIRS), is inversely related to a composite of serious postoperative complications and 30 day mortality. Our secondary hypothesis was that there is an inverse relationship between StO 2 and a composite outcome of SSI and wound-healing complications.
Methods
We report the results of a substudy of the DeLiT trial (ClinicalTrials.gov Identifier: NCT00433251), 16 a factorial randomized single-centre study designed to test the primary hypotheses that major postoperative morbidity is reduced by: (i) lowdose dexamethasone; (ii) intensive intraoperative glucose control; and (iii) lighter anaesthesia. Patients ≥40 yr of age, ASA ≤IV, undergoing elective major non-cardiac surgeries (open major vascular, major abdominal, major urological surgery) were enrolled. Exclusion criteria included: recent i.v. or oral steroid therapy (within 30 days); any contraindications to the proposed interventions; ASA physical status .IV; and procedures done under regional anaesthesia. The trial was conducted with Institutional Review Board approval and written informed consent was obtained from each participant. All patients were given general anaesthesia, and tracheal intubation, with sevoflurane in air and oxygen mixture and i.v. fentanyl infusion after a standardized anaesthetic protocol consistent with the randomization to light or deep anaesthesia. Patients were also randomized to blood glucose concentrations of 80-110 mg dl 21 20 and tissue blood saturation monitors. All have drawbacks. For example, the Clark-type electrode, while it is only minimally invasive, it is expensive and technically tricky. We thus chose an alternative non-invasive rapidly responsive approach, near-infrared spectrometry, which estimates tissue oxygen saturation from absorption of light by tissue chromophores in the 700 -1000 mm spectrum. 21 22 Specifically, we used an InSpectra StO 2 Tissue Oxygenation Monitor, Model 650 (Hutchinson Technology, Hutchinson, MN, USA). This FDA-approved device continuously measures tissue oxygen saturation at a depth of ≈15 mm under the surface from a sensor adhered to the skin. The sensor was attached to the patient's thenar eminence after anaesthetic induction, and maintained throughout surgery and for two postoperative hours. StO 2 values were recorded at 2 s intervals and downloaded into a computer for subsequent analysis; the values were not available to clinicians and therefore could not provoke changes in patient management.
Intraoperative arterial pressure was controlled to within a range of +20% to 230% of the preoperative baseline value. Heart rate was controlled to within a range of 40-90 beats min 21 . This was achieved through standardized protocol with consideration to the depth of anaesthesia, blood volume status assessment, and vasoactive drugs if required. These included nitroglycerine and/or esmolol for treating hypertension and/or tachycardia. Phenylephrine, ephedrine, and/or glycopyrrolate were used to treat hypotension and/ or bradycardia. The primary i.v. fluid was lactated Ringer's solution unless contraindicated. Up to 500 ml were given with induction of anaesthesia at the anaesthesiologist's discretion. Subsequently, lactated Ringer's solution was given as the maintenance crystalloid. Blood loss was replaced with lactated Ringer's solution at a 3:1 ratio, colloid at a 1-2:1 ratio, or red cells at a 1:1 ratio at the anaesthesiologist's discretion.
Red cell transfusions were controlled by protocol as well. Target minimum haematocrits (HCTs) were determined before operation based on the patient's cardiovascular status. The HCT was maintained at 25 -28% in patients without substantial cardiac disease, but maintained at 30% in those with significant cardiac disease (defined as previous myocardial infarction, angina, congestive heart failure, or cardiomyopathy).
Our primary outcome was a composite of 30 day mortality and serious in-hospital complications. The secondary outcome was a subset of the primary outcome composite and included deep or organ-space SSI; sepsis; internal or external fistula formation; and bowel and surgical anastomosis stricture/obstruction or anastomotic leak (Table 1) .
We assessed the associations between the collapsed composite of any major complication and time-weighted average (TWA) of all StO 2 values, and also the minimum StO 2 [defined as the minimum value sustained (+1%) over at least 5 min], using multivariable logistic regressions with the backward model selection (significance-to-stay criteria was 0.20). Few patients had an oscillometric arterial pressure cuff on the same arm as the tissue oxygen probe. Because the activation of an oscillometric arterial pressure cuff may produce a very brief period of low flow in distal tissues, followed by a brief hyperaemic period, we used 5 min as the duration over which the lowest StO 2 was sustained as a criteria to define the analysed minimum StO 2 (while it was recorded every 2 s) to eliminate any potential artifactual effect the oscillometric cuff might have had on StO 2 readings. We considered the following pre-specified potential confounders: age, gender, smoking status, type of surgery, BMI, history of coronary artery disease, congestive heart failure, stroke, chronic obstructive pulmonary disease, and transient ischaemic attacks, insulin therapy, preoperative creatinine .2.0 mg dl 21 , and HCT, and the three randomized interventions of the DeLiT trial. To account for testing two predictors of interest, we used a significance criterion of P,0.025 for each assessment (Bonferroni's adjustment to control the overall significance level at 0.05). Since this relationship may or may not be linear, we first visually assessed it by plotting the estimated probability (on the logit scale) of having the outcome as a function of StO 2 , using a univariable logistic regression incorporating a smooth (thin-plate regression spline) term for StO 2 (smoothing parameter obtained via cross-validation). We assessed the associations between the secondary outcome and the TWA of StO 2 and the minimum of StO 2 , using the same method. The fit of each model was assessed by the Hosmer-Lemeshow goodness-of-fit test. 23 In addition, intraoperative usage of vasoactive drugs and fluids management were summarized using standard summary statistics, and were compared among patients who had the primary outcome and those who did not using the standardized difference and by standard statistical tests. Standardized difference was defined as the difference in means or proportions divided by the pooled standard deviation. A standardized difference of ≤0.20 in the absolute value suggests that the compared two groups are descriptively similar.
Sample size calculations are based on the primary outcome. We assumed a standard deviation of 10% for the TWA of StO 2 and 20% for the proportion having at least one major complication from clinical experience. In order to have 85% power at the 0.025 significance level (Bonferroni's adjustment for two predictors, overall 0.05 type I error) to detect at least a 30% relative reduction in the primary outcome (i.e. an odds ratio of 0.65 or lower) per 5% increase in the TWA of StO 2 , a calculated sample size of 113 was obtained. Thus, a total sample size of 124 patients, allowing for 10% drop-out was selected to ensure an adequately powered study.
For our main analysis, we used the logistic procedure in SAS software version 9.2 for Windows (SAS Institute, Cary, NC, USA) and the gam function available in the mgcv library for R software version 2.8.1 for Windows (The R Foundation for Statistical Computing, Vienna, Austria). R was used for graphics.
Results Table 2 provides a summary of patient characteristic, baseline, and intraoperative characteristics of the 124 patients who were enrolled. The incidence of the primary composite postoperative morbidity was 19% (Table 1) . For individual morbidity, the incidence observed ranged from 0% to 13%, with deep-or organ-space SSI being the single most common serious complication.
The observed median TWA StO 2 from incision to 2 h after arrival in recovery was 85% [79-90% (1st-3rd quartile)] and the median minimum StO 2 was 78% [70-85%]. We also observed 17 (14%) patients with a TWA of StO 2 ,75% and 3 (2%) patients with a TWA of StO 2 exceeding 95%. The median analysed StO 2 time period was 6.2 [5.2-7.9] h.
The minimum of StO 2 was inversely associated with the primary outcome-collapsed composite of 30 day mortality and serious in-hospital complications (P¼0.02); the estimated odds ratio was 0.82 (97.5% CI: 0.67, 1.00) for a 5% increase in the minimum of StO 2 . Unlike minimum StO 2 , TWA StO 2 was not significantly associated with our primary outcome (P¼0.35) with an odds ratio of 0.89 (97.5% CI: 0.66, 1.19) for a 5% increase in the TWA. Both analyses were adjusted for BMI, the only covariable which entered the multivariable model out of the 16 pre-specified potential confounders (detailed in the Methods section). The assumption of linearity was reasonable for both predictors of interest (Fig. 1) ; the Hosmer-Lemeshow goodness-of-fit test results do not suggest lack of fit in any of the models.
Neither TWA StO 2 (P¼0.65) nor minimum StO 2 (P¼0.70) was significantly associated with our secondary outcome, collapsed composite of major infections, and wound-healing complications, after adjusting for BMI. The estimated odds ratios (95% CI) were 1.08 (0.78, 1.50) and 0.96 (0.79, 1.18) for a 5% increase in TWA StO 2 and in minimum StO 2 , respectively.
We also observed that patients who had a primary outcome and those who did not were descriptively similar (absolute standardized difference ≤0.20) on amount of ephedrine, epinephrine, esmolol, metoprolol, and cell saver transfusion during surgery (Table 3 ). Although patients who had a primary outcome, on average, were more likely to receive more phenylephrine, labetalol, colloid, and red blood cell, and received less nitroglycerine, norepinephrine, and crystalloid (absolute standardized difference .0.20). The differences were not statistically different (except for colloid), but none of the differences were clinically significant (Table 3) .
Discussion
NIRS, based on the Beer -Lambert law, evaluates the amount of haemoglobin in tissues crossed by the near-infrared light. 24 It primarily measures the per cent haemoglobin oxygen saturation in the capillaries, venules, and arterioles
Tissue oxygenation and surgical outcomes of the microcirculation of peripheral tissue with a diameter ,1 mm because the high concentration of blood in arteries and veins makes photon emergence unlikely. 25 That said, the monitored tissue segment is somewhat poorly defined and for simplicity is referred to as 'tissue oxygenation'. In healthy volunteers, normal tissue oxygen saturation is 87 (69%) [mean (SD)] obtained by NIRS at the thenar eminence. 26 This is similar to that of our cohort of non-cardiac surgery patients in whom the median [1st, 3rd quartile] was 85% [79%, 90%] during the intraoperative and immediate postoperative period. Temporary hypoxia in acute wounds serves as a signal that stimulates many aspects of the wound-healing process. In contrast, prolonged or chronic hypoxia delays wound healing. 6 27 For example, an StO 2 threshold of 75% provides a good positive predictive value and positive likelihood ratio for predicting low central venous oxygen saturation-values which reflect overall state of systemic oxygenation. 28 Similar findings were reported in non-surgical settings where peripherally measured StO 2 in heart failure patients correlated with hospitalization for heart failure and mortality. 13 We nonetheless found that minimum StO 2 , rather than TWA StO 2 , was associated with poor postoperative composite outcome-a result suggesting that episodes of extreme tissue hypoxia contribute more to adverse outcomes than periods of relative tissue hypoxia and hypoperfusion. We observed a significant and potentially clinically important association between minimum (mostly intraoperative) StO 2 and a composite of serious outcomes. StO 2 -measure of systemic oxygenation 24 -is associated with a composite of systemic complications which is perhaps unsurprising. But curiously, there was no independent association between StO 2 and infectious complications. This result thus differs somewhat from those reported by Govinda and wound, upper arm, and thenar eminence-but only observed a significant association between StO 2 measured at the upper arm and SSI. Thus, timing of measurements and the measurement site may both prove to be important. We measured StO 2 continuously during surgery and for the first 2 h of the immediate postoperative period. In contrast, Govinda and colleagues measured StO 2 75 min after surgery and 1 day after the operation. By virtue of our continuous measurements, our measurements might better represent the perioperative period. This is especially the case since the time frame we evaluated represents the surgical insult and the time when patients' care is anaesthesiologist-driven. If it were shown to be helpful, anaesthesiologists could implement a myriad of interventional strategies to improve tissue oxygenation such as supplemental oxygen, vascular volume repletion, treatment of pain, etc. An additional difference between our current study and Govinda and colleagues is that we studied patients undergoing a range of major noncardiac surgeries and evaluated the impact of StO 2 on a composite of systemic outcomes and wound-healing complications, whereas the previous study was restricted to colon resection and evaluated only wound-related infectious complications. We also note that both studies were relatively small and spurious associations remain a risk-although our analysis was based on an a priori plan and included statistical compensations for various analyses. Tissue oxygen partial pressure is probably the best single predictor of wound infection risk. 3 As might thus be expected, low StO 2 at the distal colon anastomosis is a risk factor for anastomotic dehiscence after operation. 9 Furthermore, several randomized trials conclude that supplemental perioperative oxygen (80% vs 30%), which normally roughly doubles tissue oxygenation, 10 halves the risk of surgical wound infection. 10 11 Others, although, have found that infection rates are similar with and without supplemental oxygen, including the PROXI trial in which 1400 patients were randomized to receive 80% or 30% of supplemental oxygen intraoperatively and 2 h after operation. 29 The divergent results are difficult to explain, but a variety of factors besides inspired 31 32 suture tension, 31 surgical tissue oedema, 33 and local and core temperature. 34 To the extent that other factors-such as hypovolaemia-limit oxygen delivery to peripheral tissues, supplemental oxygen alone may be insufficient in some patients. In our study, patients were receiving a mixture of air and oxygen (1:1) resulting in an FI O 2 of 55%. The intriguing aspect of non-invasively measuring tissue oxygenation is that it opens the possibility of intervening to improve oxygenation in individual patients. For example, minimum StO 2 were plotted along the x-axes. Probabilities were estimated using univariable logistic regressions with a smooth term for StO 2 .
All patients (n¼124) were used for the estimation; however, the x-axes were truncated due to sparse data at the ends (seven patients for the TWA and 14 patients for the minimum).
supplemental oxygen could be followed-if necessary-with vascular volume repletion, measures to increase cardiac output, vasodilators, or local and/or system warming. 35 Such progressive interventions may be more effective than simply providing supplemental oxygen to all patients. But whether this approach will actually reduce wound-related complications remains to be determined in randomized intervention trials. Promising results have been shown already in studying similar concepts. Intraoperative fluid replacement based on the measurement of subcutaneous oxygen tension (PscO 2 ) vs clinical judgement has been shown to correlate favourably with the collagen deposits, indicative of better wound healing. 36 Red blood cell transfusions have shown an improvement in global measures of oxygen delivery but not in oxygen consumption. 37 However, whether an improvement in oxygen delivery and consumption translate into an actual increase in regional tissue oxygenation is still controversial. Several recent studies using NIRS technology has suggested that blood transfusion may improve tissue oxygenation, 38 -40 although others have not. 41 42 Furthermore, the added impact of stored red cell age while being explored in a variety of clinical settings did not show any effect on tissue oxygenation. 41 In our study, red blood cell transfusion was controlled per protocol, and our blood bank that was blinded to the study used the same unit allocation strategy for all patients who needed transfusion. Therefore, we had no reason to believe that red blood cell age or transfusion had any significant impact on our results. The use of vasopressors may also impact tissue perfusion; however, the clinical significance of such a very small impact on tissue oxygenation is questionable. 43 In our study, there was no difference between the patients who had a primary outcome and those who did not in the use of vasopressors. We chose the thenar eminence as our measurement site partially because it has been used in previous studies, because the site resists oedema, and because it is an area that rarely accumulates substantial adiposity. 44 We nonetheless adjusted our analysis for BMI. All our patients had major surgery and thus usually had i.v. catheters inserted in both arms. Generally, fluid was warmed to body temperature when given rapidly, and slow infusions have little effect on tissue temperature, even near the infusion site. The InSpectra StO 2 monitor used reports an accurate value for StO 2 regardless of body temperature. 45 Our study is limited by its observational cohort design; we are thus unable to determine causality from our results. Oxygenation in various tissues can obviously diverge depending on local perfusion. For example, supplemental perioperative fluid improves subcutaneous oxygen partial pressure in the upper arm, 46 but does not appear to reduce the risk of SSI in colectomy patients 47 -perhaps because interstitial oedema actually reduces oxygenation in the tissue of interest. 33 However, the aforementioned study by Kabon and colleagues was stopped early. If the difference in infection rates (11.3 vs 8.5%) had held up with a sufficient sample size, the 25% absolute reduction in infection rate could have been clinically important. It should be noted that a recent preclinical study in pigs indicated that gut tissue oxygenation was not affected by low-, moderate-, or high-volume resuscitation techniques. 48 The same group of authors demonstrated that goal-directed fluid therapy with colloids improved gut oxygenation that was not affected by goal-directed fluid therapy with crystalloids or restrictive fluid administration. 49 Whether these results translate into similar findings in other non-mesenteric tissues is largely unknown. In support of this concern, oesophageal Doppler goal-directed fluid management has resulted in inconsistent results in terms of StO 2 .
50
A second limitation is that we measured StO 2 at the thenar eminence without simultaneous measurements at or near the surgical site which might better reflect saturation in wounds and other tissues of interest. However, intraoperative measurements near the surgical sites are rarely practical. Any study evaluating the effect of various StO 2 interventions on outcomes would thus have to be based on measurements at some site remote to the surgical incision.
In summary, minimum perioperative peripheral tissue oxygenation predicted a composite of major complications and mortality in patients having major non-cardiac surgery. However, this is an observational association. Whether clinical interventions to augment tissue oxygenation will improve outcomes remains to be determined.
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